144 related articles for article (PubMed ID: 19638463)
1. Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients.
Pugh TJ; Keyes M; Barclay L; Delaney A; Krzywinski M; Thomas D; Novik K; Yang C; Agranovich A; McKenzie M; Morris WJ; Olive PL; Marra MA; Moore RA
Clin Cancer Res; 2009 Aug; 15(15):5008-16. PubMed ID: 19638463
[TBL] [Abstract][Full Text] [Related]
2. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.
Cesaretti JA; Stock RG; Lehrer S; Atencio DA; Bernstein JL; Stone NN; Wallenstein S; Green S; Loeb K; Kollmeier M; Smith M; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):196-202. PubMed ID: 15629612
[TBL] [Abstract][Full Text] [Related]
3. Significance of amino acid substitution variants of DNA repair genes in radiosusceptibility of cervical cancer patients; a pilot study.
Farkasova T; Gurska S; Witkovsky V; Gabelova A
Neoplasma; 2008; 55(4):330-7. PubMed ID: 18505345
[TBL] [Abstract][Full Text] [Related]
4. Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients.
Langsenlehner T; Renner W; Gerger A; Hofmann G; Thurner EM; Kapp KS; Langsenlehner U
Radiother Oncol; 2011 Mar; 98(3):387-93. PubMed ID: 21345510
[TBL] [Abstract][Full Text] [Related]
5. Constitutive mRNA expression of DNA repair-related genes as a biomarker for clinical radio-resistance: A pilot study in prostate cancer patients receiving radiotherapy.
Hümmerich J; Werle-Schneider G; Popanda O; Celebi O; Chang-Claude J; Kropp S; Mayer C; Debus J; Bartsch H; Schmezer P
Int J Radiat Biol; 2006 Aug; 82(8):593-604. PubMed ID: 16966187
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients.
Chistiakov DA; Voronova NV; Chistiakov PA
Acta Oncol; 2008; 47(5):809-24. PubMed ID: 18568480
[TBL] [Abstract][Full Text] [Related]
7. To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.
Valdagni R; Rancati T; Ghilotti M; Cozzarini C; Vavassori V; Fellin G; Fiorino C; Girelli G; Barra S; Zaffaroni N; Pierotti MA; Gariboldi M
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1431-40. PubMed ID: 19211196
[TBL] [Abstract][Full Text] [Related]
8. A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy.
Hall EJ; Schiff PB; Hanks GE; Brenner DJ; Russo J; Chen J; Sawant SG; Pandita TK
Cancer J Sci Am; 1998; 4(6):385-9. PubMed ID: 9853138
[TBL] [Abstract][Full Text] [Related]
9. DNA repair gene polymorphisms, tumor control, and treatment toxicity in prostate cancer patients treated with permanent implant prostate brachytherapy.
Carignan D; Lessard T; Villeneuve L; Desjardins S; Magnan S; Després P; Martin AG; Foster W; Guillemette C; Lévesque É; Vigneault E
Prostate; 2020 May; 80(8):632-639. PubMed ID: 32201973
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in normal tissue toxicity induced by ionizing radiation.
Popanda O; Marquardt JU; Chang-Claude J; Schmezer P
Mutat Res; 2009 Jul; 667(1-2):58-69. PubMed ID: 19022265
[TBL] [Abstract][Full Text] [Related]
11. Single-nucleotide polymorphisms studied for associations with urinary toxicity from (125)I prostate brachytherapy implants.
Usmani N; Leong N; Martell K; Lan L; Ghosh S; Pervez N; Pedersen J; Yee D; Murtha A; Amanie J; Sloboda R; Murray D; Parliament M
Brachytherapy; 2014; 13(3):285-91. PubMed ID: 24656733
[TBL] [Abstract][Full Text] [Related]
12. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
[TBL] [Abstract][Full Text] [Related]
13. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility.
Vineis P; Manuguerra M; Kavvoura FK; Guarrera S; Allione A; Rosa F; Di Gregorio A; Polidoro S; Saletta F; Ioannidis JP; Matullo G
J Natl Cancer Inst; 2009 Jan; 101(1):24-36. PubMed ID: 19116388
[TBL] [Abstract][Full Text] [Related]
14. Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients.
Severin DM; Leong T; Cassidy B; Elsaleh H; Peters L; Venter D; Southey M; McKay M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1323-31. PubMed ID: 11483345
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in genes involved in androgen pathways as risk factors for prostate cancer.
Mononen N; Schleutker J
J Urol; 2009 Apr; 181(4):1541-9. PubMed ID: 19230916
[TBL] [Abstract][Full Text] [Related]
16. Increased radiosensitivity as an indicator of genes conferring breast cancer susceptibility.
Varga D; Vogel W; Bender A; Surowy H; Maier C; Kreienberg R; Deissler H; Sauer G
Strahlenther Onkol; 2007 Dec; 183(12):655-60. PubMed ID: 18040608
[TBL] [Abstract][Full Text] [Related]
17. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
18. [Genetic determinants of radiation sensitivity in LDR brachytherapy of prostate carcinoma].
Meyer A
Urologe A; 2007 Sep; 46(9):1103-4. PubMed ID: 17628771
[No Abstract] [Full Text] [Related]
19. Finding the genetic determinants of adverse reactions to radiotherapy.
Rattay T; Talbot CJ
Clin Oncol (R Coll Radiol); 2014 May; 26(5):301-8. PubMed ID: 24702740
[TBL] [Abstract][Full Text] [Related]
20. Prostate-cancer-associated I260M variant of DNA polymerase beta is a sequence-specific mutator.
Dalal S; Hile S; Eckert KA; Sun KW; Starcevic D; Sweasy JB
Biochemistry; 2005 Dec; 44(48):15664-73. PubMed ID: 16313169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
